Background. Left 
T here is growing evidence that survival after acute myocardial infarction is related to remodeling of noninfarcted myocardium.1-3 Loss of myocardium triggers acute and chronic responses that restore stroke volume. The acute distension of noninfarcted myocardium, activation of the Frank-Starling mechanism, and adrenergic stimulation combine to restore cardiac performance. However, when myocardial damage is extensive, these compensatory mechanisms are inadequate, resulting in chronic left ventricular dilation and increased wall stress. If the latter is not entirely reversed by myocyte hypertrophy, then progressive left ventricular enlargement, deterioration in cardiac performance, and increased mortality will ensue. [3] [4] [5] [6] Recent studies have examined the possibility that interventions that prevent progressive left ventricular enlargement improve survival.3
Milrinone, a phosphodiesterase inhibitor with positive inotropic and vasodilator properties, provides symptomatic relief to patients with left ventricular dysfunction.7 Improvement in survival after acute myocardial infarction in rats treated with milrinone8 has been observed and may be related to effects on left ventricular remodeling. The purpose of this investigation was to test the hypothesis that milrinone alters left ventricular remodeling and prevents progressive left ventricular dilation after acute myocardial infarction.
Methods

Experimental Myocardial Infarction
Female Sprague-Dawley rats (n=90) weighing 200-225 g underwent either left coronary artery ligation or sham operation. After anesthesia with 35 mg/kg methohexital i.p. and local anesthesia with 1% xylocaine, the trachea was exposed in the midline and the rats were intubated under direct vision and ventilated with room air. The chest was opened by anterolateral thoracotomy, and the pericardium was removed. The heart was retracted with an apical suture, and the left coronary artery was occluded with a 6-0 silk suture 1-2 mm below the left atrial appendage. Successful occlusion was confirmed by pallor of the anterior wall of the left ventricle and ST segment elevation. If neither change was observed, the occlusion was repeated. The incisions were closed and 100,000 units benzathine penicillin was administered intramuscularly as a prophylaxis against infection. The rats were extubated and allowed to recover in individual cages. Sham animals underwent an identical procedure without coronary ligation. All rats received standard care including ad libitum food and water and a 12-hour day/night cycle.
Randomization and Treatment
Before surgery, the -rats were randomized to one of four groups: group 1, left coronary ligation and no treatment (n=29); group 2, left coronary ligation and milrinone (n=31); group 3, sham surgery and no treatment (n = 15); and group 4, sham surgery and milrinone (n = 15). Three weeks after surgery, milrinone was added to the drinking water (15 mg/I) of the two treatment groups. Therapy was continued for 3 months after surgery until 48 hours before hemodynamic measurements, after which the rats were killed. Hemodynamics
Forty-eight hours after milrinone was discontinued (24 half-lives), rats were anesthetized intraperitoneally with ketamine (60 mg/kg) and diazepam (7.5 mg/kg), intubated, and ventilated. A catheter was inserted into the left femoral vein for volume infusion. The chest was opened by a left parasternal incision and a 2.5 -mm electromagnetic flow probe was placed around the ascending aorta. After a stabilization period of 10 minutes, a saline-filled 1-in. 21-gauge needle was inserted into the left ventricular cavity through noninfarcted myocardium and connected to a 5F micromanometer-tipped catheter through a short, plastic connector. Baseline hemodynamic measurements including heart rate, left ventricular pressure, left ventricular dP/dt, and cardiac output were recorded on an eight-channel HewlettPackard (Palo Alto, Calif.) recorder with the respirator temporarily disconnected.
The peak flow generating capacity of the heart was evaluated by infusion of 40 ml/kg/min of Ringer's lactate at 37°C with continuous recording of all hemodynamic parameters until the peak cardiac output was attained.
At the conclusion of hemodynamic studies, the hearts were arrested by infusion of 30 mM KCl through the femoral vein, excised, and placed in ice-cold KCl to achieve uniform diastolic arrest.
Pressure-Volume Measurement
The passive pressure-volume relation of the left ventricle was determined within 10 minutes of cardiac arrest. After the hearts were removed, a doublelumen catheter was inserted into the left ventricular cavity through the aortic valve. The aorta was ligated around the catheter, and the atrioventricular groove was tied off to isolate the left ventricular cavity. The right ventricle was incised to prevent left ventricular compression. After gentle compression to remove all residual fluid from the left ventricle, normal saline was infused at 0.68 ml/min and left ventricular pressure was simultaneously recorded to produce pressure-volume curves over a range of 0-40 mm Hg.
Fixation and Preparation of the Heart
With the heart submerged in formalin, 10% phosphate-buffered formalin was infused continuously into the left ventricular cavity through the doublelumen catheter for 24 hours. The height of the exit port on the catheter resulted in a fixation pressure of 7.5 mm Hg and was constant for all hearts. After fixation, the hearts were weighed and then cut transversely from apex to base into four slices. Each slice was weighed, and the thickness was measured. Photographs of both sides of each slice were taken.
Analysis of Data
Hemodynamics. Resting heart rate, left ventricular pressure, dP/dt, and mean and phasic cardiac output were measured over six cardiac cycles and averaged. Left ventricular end-diastolic pressure was measured at the onset of the rapid rise of dP/dt. Cardiac index was calculated as cardiac output per kilogram of body weight. Peak hemodynamic measurements were made at the time of maximum cardiac output during the volume loading and averaged over six cycles.
Prefixation left ventricular volume measurement. Left ventricular volume was recorded from the pressurevolume curve at a pressure corresponding to the peak left ventricular end-diastolic pressure obtained during volume loading and corrected for body weight at the time the rats were killed.
Postfixation left ventnicular volume measurement.
After fixation, the base of the heart was excised at the level of the atrioventricular groove. The cavity was blotted dry and then filled to capacity with normal saline using a 1-ml tuberculin syringe for direct estimation of left ventricular volume. Two determinations were averaged for each heart and corrected for body weight.
Left ventricular wall stress. An index of left ventricular end-diastolic wall stress was calculated by dividing postfixation left ventricular end diastolic volume by the heart weight.
Left ventricular chamber and myocardial stiffness. Ventricular volumes were determined from the passive pressure-volume curves at every 1 mm Hg from 0 to 40 mm Hg. A curve for each group was constructed from the mean volumes at each unit of pressure. Left ventricular chamber stiffness was expressed as dP/dv/p.
An estimate of myocardial stiffness was made by multiplying left ventricular chamber stiffness constant and volume-to-mass ratio of the left ventricle. 9 Infarct size measurement. 
Hemodynamic Measurements
In infarcted rats, milrinone lowered left ventricular end-diastolic pressure at rest and at peak flow generating capacity to a level that did not differ from that found in uninfarcted animals (Figures 1 and 2) . In uninfarcted rats, milrinone had no effect on left ventricular end-diastolic pressure. Other hemodynamic parameters, including heart rate, left ventricular systolic pressure, positive dP/dt, and cardiac index, were not altered by milrinone at rest (Table 1) or at peak flow generating capacity (Table 2) in either infarcted or uninfarcted rats.
Left Ventricular Volume
Left ventricular volumes were increased in both milrinone-treated and untreated infarcted rats but more so in untreated infarcted rats (milrinone treated, 1.25+0.20 ml/kg; untreated, 2.37±0.30 ml/ kg;p<0.001; Figure 3 ). Arranging the left ventricular cavity volume data in each group from the lowest to the highest value in a quantile-quantile plot (Figure 4) demonstrated that milrinone had a favorable effect on volume in all heart sizes. Milrinone had no effect on left ventricular volume in uninfarcted hearts (milrinone-treated, 0.83 0.10 ml/kg; untreated, 1.12±+0.15 ml/kg; p=NS; Figure 3 ). Postfixation volumes are shown in Table 3 ; although they were lower than prefixation volumes, results from the two volume techniques were closely correlated (r=0.83, Figure 5 ).
Left Ventricular Wall Stress
Wall stress was increased in both milrinonetreated and untreated infarcted rats, but the increase was less in milrinone-treated infarcted rats (Table 3) . Milrinone had no effect on wall stress in uninfarcted 
Pressure-Volume Curves
The lower left ventricular volumes in the milrinone-treated rats were not entirely due to lower filling pressures and a move along a single pressurevolume curve. When the curves for the four groups were compared (Figure 6 (Table 4 ). The chamber stiffness constant of infarcted milrinone-treated rats was higher than that of infarcted untreated rats. The chamber stiffness constants of untreated and milrinone-treated uninfarcted rats were similar. Estimated left ventricular myocardial stiffness was similar in all four groups of animals (Table 4) .
Discussion
The principal finding of this study was that chronic treatment with milrinone attenuates progressive left Milrinone improved hemodynamic parameters at rest and at peak cardiac output, decreased wall stress, increased left ventricular chamber stiffness, and resulted in left ventricular volumes that were less than half the volumes in untreated infarcted hearts with similar sized infarcts. Left ventricular myocardial stiffness was not altered by milrinone therapy.
Determinants of Ventricular Remodeling
An acute myocardial infarction causes an immediate compensatory increase in left ventricular volume and activation of the Frank-Starling mechanism, which restores stroke volume. Over the ensuing weeks to months, remodeling of noninfarcted myocardium can result in progressive left ventricular dilation, which is pathological rather than compensatory and is associated with increased mortality.1-6 Although infarct characteristics including size, extent of transmurality, location, and extent of expansion can affect left ventricular remodeling, they were not a factor in this experiment because milrinone treatment was not started until healing of the infarct was complete. Changes in left ventricular size and func- were used in this study: 1) the prefixation method, which has the advantage of volume measurement at a predictable left ventricular end-diastolic pressure (i.e., left ventricular end-diastolic pressure at peak pumping capacity); and 2) the postfixation method, a simpler technique that correlated well with the prefixation method. This is because both peak left ventricular end-diastolic pressure and the fixation pressure for the postfixation technique (7.5 mm Hg) occurred on the steep portion of the pressure-volume curve in all four groups of rats.
Clinical Implications
Progressive ventricular dilation may temporarily restore diminished stroke volume, but it can become mechanically disadvantageous, resulting in worsening congestive heart failure.27 Increased left ventricular volume is a predictor of decreased survival, and interventions that attenuate volume increases should decrease symptoms of congestive heart failure and improve survival. Captopril, which reduces progressive left ventricular dilation after myocardial infarction experimentally and clinically, improves survival with moderate-sized infarcts.3 Improved survival with milrinone after myocardial infarction in rats8 may be related to attenuation of progressive left ventricular dilation observed in this study. Clinical studies with milrinone have raised concerns about deterioration of left ventricular function2829 and increased incidence of ventricular arrhythmias.30 An ongoing trial is investigating the effect of milrinone on survival in patients with severe left ventricular dysfunction. 31 The beneficial effects of milrinone on left ventricular function seen in the current study may not be seen with intervention at a very late stage of disease when the left ventricle has no inotropic reserve and is already severely dilated.
